Free Trial

Strs Ohio Buys Shares of 10,437 The Clorox Company $CLX

Clorox logo with Consumer Staples background

Key Points

  • Strs Ohio has invested approximately $1.54 million in The Clorox Company, acquiring 10,437 shares in the first quarter.
  • Multiple hedge funds are adjusting their positions in Clorox, with 78.53% of the stock owned by institutions, indicating increased investment interest.
  • Clorox has announced a quarterly dividend of $1.24, representing a 4.0% yield, which will be paid on November 6th to investors of record by October 22nd.
  • Interested in Clorox? Here are five stocks we like better.

Strs Ohio purchased a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 10,437 shares of the company's stock, valued at approximately $1,537,000.

Other institutional investors have also recently bought and sold shares of the company. Hsbc Holdings PLC boosted its holdings in shares of Clorox by 118.8% during the 1st quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company's stock worth $159,699,000 after buying an additional 589,544 shares during the period. KBC Group NV grew its position in shares of Clorox by 688.7% during the 1st quarter. KBC Group NV now owns 587,679 shares of the company's stock worth $86,535,000 after buying an additional 513,171 shares during the period. AQR Capital Management LLC grew its position in shares of Clorox by 412.1% in the 1st quarter. AQR Capital Management LLC now owns 598,758 shares of the company's stock valued at $88,167,000 after purchasing an additional 481,846 shares during the period. Goldman Sachs Group Inc. raised its stake in shares of Clorox by 147.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 707,005 shares of the company's stock worth $104,107,000 after purchasing an additional 421,453 shares in the last quarter. Finally, GAMMA Investing LLC increased its holdings in shares of Clorox by 11,108.0% during the 1st quarter. GAMMA Investing LLC now owns 349,130 shares of the company's stock worth $51,409,000 after acquiring an additional 346,015 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on CLX shares. Wells Fargo & Company decreased their target price on Clorox from $138.00 to $130.00 and set an "equal weight" rating for the company in a research note on Friday, September 5th. Jefferies Financial Group dropped their price target on Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research note on Thursday, June 26th. UBS Group lowered their price target on Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a research report on Thursday, July 17th. JPMorgan Chase & Co. upped their price target on Clorox from $133.00 to $135.00 and gave the stock a "neutral" rating in a research note on Monday, September 8th. Finally, Morgan Stanley decreased their target price on Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a report on Friday, August 1st. One research analyst has rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Reduce" and a consensus price target of $142.18.

Check Out Our Latest Stock Analysis on CLX

Insider Activity at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the business's stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.57% of the stock is currently owned by corporate insiders.

Clorox Price Performance

Shares of CLX traded down $2.21 during mid-day trading on Friday, hitting $121.91. The company's stock had a trading volume of 5,300,123 shares, compared to its average volume of 1,766,696. The firm has a 50-day moving average price of $124.04 and a 200 day moving average price of $131.40. The stock has a market capitalization of $14.91 billion, a price-to-earnings ratio of 18.70, a PEG ratio of 1.00 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The Clorox Company has a fifty-two week low of $116.53 and a fifty-two week high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm had revenue of $1.99 billion during the quarter, compared to analysts' expectations of $1.94 billion. During the same period in the previous year, the company earned $1.82 earnings per share. The company's revenue was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, research analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a dividend yield of 4.1%. Clorox's payout ratio is currently 76.07%.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.